Elektra Health, MD-Led Platform

Elektra Health is a New York-based menopause telehealth company founded in 2019 by Jannine Versi with a dual mission: deliver clinical menopause care, and simultaneously destigmatize the menopause conversation in mainstream healthcare. The company's tagline — "smashing the menopause taboo" — reflects a founding conviction that menopause is undertreated partly because of cultural silence and partly because the healthcare system has historically provided inadequate training and reimbursement for menopause medicine. Elektra's care model distinguishes itself through its coaching layer. Every patient is paired 1:1 with an Elektra Coach — a trained menopause educator who is not a clinician but plays a meaningful role in the care experience: helping patients interpret their symptoms, set behavioral goals, understand their treatment plan, and ask better questions in clinical visits. This coaching model reflects a growing body of evidence that the outcomes gap in menopause care is not solely a prescribing problem — many women receive a prescription but struggle to manage side effects, adhere to treatment, or address the lifestyle factors (sleep hygiene, stress, nutrition, weight) that interact with hormone therapy outcomes. The coach provides the continuity and support that a 30-minute clinical visit cannot. On the clinical side, Elektra employs board-certified clinicians trained in menopause medicine who can prescribe both hormonal and non-hormonal treatments, including FDA-approved estrogen and progesterone preparations, low-dose SSRIs and SNRIs for vasomotor symptoms, and evidence-backed non-prescription supplements. The platform also addresses menopause-adjacent conditions — high cholesterol, hypothyroidism, hypertension, anxiety, and depression — within the context of the menopause transition. Elektra's insurance strategy has been one of the most aggressive in the category. The company signed its first payer partner in 2024 and grew to nearly 40 partners by the end of 2025, including major commercial carriers in New York and a growing national footprint. The company's most significant payer innovation came in late 2025 when it co-developed HelloMeno with Oscar Health — the first ACA marketplace health plan designed specifically around menopause care. Launching in January 2026 across 11 states, HelloMeno covers primary care and GYN visits, behavioral health, HRT, lab work, and bone density scans at no cost to members, with an estimated annual savings of $900 per enrollee compared to standard plan costs for menopause management. This makes Elektra one of the few menopause telehealth providers operating simultaneously as a clinical service and a health plan architect. The company's tagline — "smashing the menopause taboo" — reflects a founding conviction that menopause is undertreated partly because of cultural silence and partly because the healthcare system has historically provided inadequate training and reimbursement for menopause medicine. Elektra's care model distinguishes itself through its coaching layer. Every patient is paired 1:1 with an Elektra Coach — a trained menopause educator who is not a clinician but plays a meaningful role in the care experience: helping patients interpret their symptoms, set behavioral goals, understand their treatment plan, and ask better questions in clinical visits. This coaching model reflects a growing body of evidence that the outcomes gap in menopause care is not solely a prescribing problem — many women receive a prescription but struggle to manage side effects, adhere to treatment, or address the lifestyle factors (sleep hygiene, stress, nutrition, weight) that interact with hormone therapy outcomes. The coach provides the continuity and support that a 30-minute clinical visit cannot. On the clinical side, Elektra employs board-certified clinicians trained in menopause medicine who can prescribe both hormonal and non-hormonal treatments, including FDA-approved estrogen and progesterone preparations, low-dose SSRIs and SNRIs for vasomotor symptoms, and evidence-backed non-prescription supplements. The platform also addresses menopause-adjacent conditions — high cholesterol, hypothyroidism, hypertension, anxiety, and depression — within the context of the menopause transition. Elektra's insurance strategy has been one of the most aggressive in the category. The company signed its first payer partner in 2024 and grew to nearly 40 partners by the end of 2025, including major commercial carriers in New York and a growing national footprint. The company's most significant payer innovation came in late 2025 when it co-developed HelloMeno with Oscar Health — the first ACA marketplace health plan designed specifically around menopause care. Launching in January 2026 across 11 states, HelloMeno covers primary care and GYN visits, behavioral health, HRT, lab work, and bone density scans at no cost to members, with an estimated annual savings of $900 per enrollee compared to standard plan costs for menopause management. This makes Elektra one of the few menopause telehealth providers operating simultaneously as a clinical service and a health plan architect.